Location Natick, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Arthur Combs is a physician executive with a lifelong experience in the medical products industry. First, as a customer and expert end-user during more than 20 years in academic medicine in the device and technology-intensive specialty of Critical Care Medicine, and second, as an executive, corporate officer and consultant across the medical
products industry.
In 1997, Dr. Combs became the first Medical Director for Mallinckrodt Inc.’s respiratory care business that included Nellcor, Puritan-Bennett, Shiley and Mallinckrodt’s own products. From that position he then became Executive VP, R&D. On his watch, Nellcor’s 4th generation oximetry platform, the PMA fetal pulse oximeter, and the flagship PB 840 ventilator were cleared and launched. Mallinckrodt was purchased by Tyco International (now Covidien) in 2000.
Dr. Combs has been a retained consultant for HP Medical, Agilent Technologies, Philips Medical Systems, Edwards Life Sciences and many others. His projects have included automated ventilation management, continuous arterial blood gas monitoring, proteomics, molecular diagnostics, noninvasive cardiac output technologies, and tight glycemic control. He has also consulted for numerous Venture Capital firms with a life sciences focus.
As an entrepreneur, Dr. Combs has previously been an officer of 3 start-up medical device companies. Everest Biomedical Instruments, where he was VP, R&D and CMO, sold its first noninvasive product to Viasys Corporation, spun out its second device as BrainScope, Inc. and sold its third noninvasive product and the company to Stryker International in 2005. BMEYE BV of Amsterdam, Netherlands, maker of noninvasive continuous cardiac output technology, hired Dr. Combs as CMO and GM, North America. After BMEYE obtained both CE Mark and US FDA clearance for their Nexfin products, Dr. Combs left to become CEO of Grove Instruments.
In addition to contributing to the technical and clinical development of more than half a dozen innovative noninvasive medical devices currently on the market, Combs has raised tens of millions of dollars in equity capital, grants, and awards. He is an alumnus of the University of Notre Dame, New York Medical College and Memorial Sloan Kettering Cancer Center. Dr. Combs is co-inventor on 2 issued US patents. He holds honorary fellowships in the American College of Chest Physicians and the American College of Critical Care Medicine.
